Assignee
ABL BIO INC
KR·11 granted patents·14 pending applications·11 citations·filing 2018–2025
Top patents by PatentIndex Score
25 records- 0186US11891445B1Anti-B7-H3 antibody and use thereofABL BIO INC·Filed 2019·Granted Feb 6, 2024·5 cites·14 claims
- 0278US12240913B2Anti-HER2/anti-4-1BB bispecific antibody and use thereofABL BIO INC·Filed 2020·Granted Mar 4, 2025·1 cites·6 claims
- 0377US12195538B2Anti-PD-L1/anti-4-1BB bispecific antibodies and uses thereofABL BIO INC·Filed 2019·Granted Jan 14, 2025·1 cites·10 claims
- 0476US2025115670A1Bispecific antibody against alpha-syn/igf1r and use thereofABL BIO INC·Filed 2024·Application pending·0 cites
- 0575US12252541B2Anti-BCMA antibody and use thereofABL BIO INC·Filed 2019·Granted Mar 18, 2025·2 cites·9 claims
- 0675US12195537B2Anti-4-1BB antibody and use thereofABL BIO INC·Filed 2019·Granted Jan 14, 2025·1 cites·4 claims
- 0773US12071483B1Bispecific antibody to alpha-synuclein/insulin-like growth factor 1 receptor and use thereofABL BIO INC·Filed 2018·Granted Aug 27, 2024·1 cites·18 claims
- 0871US2025066487A1Anti-egfr/anti-4-1bb bispecific antibody and use thereofABL BIO INC·Filed 2024·Application pending·0 cites
- 0970US2023357412A1Bispecific antibody against alpha-syn/igf1r and use thereofABL BIO INC·Filed 2022·Application pending·0 cites
- 1068US2024101687A1Bispecific Antibody to A-Syn/IGF1R and Use ThereofABL BIO INC·Filed 2023·Application pending·0 cites
- 1164US2025145718A1Anti-pd-l1/anti-4-1bb bispecific antibodies and uses thereofABL BIO INC·Filed 2025·Application pending·0 cites
- 1260US2022348665A1BISPECIFIC ANTIBODY AGAINST Alpha-SYN/IGF1R AND USE THEREOFABL BIO INC·Filed 2020·Application pending·0 cites
- 1359US2026015418A1Anti-ror1 antibody, bispecific antibody comprising same, and uses thereofABL BIO INC·Filed 2023·Application pending·0 cites
- 1455US12168690B2Anti-EGFR/anti-4-1BB bispecific antibodyABL BIO INC·Filed 2020·Granted Dec 17, 2024·0 cites·6 claims
- 1554US2025084158A1Anti-cll-1 antibodies and uses thereofABL BIO INC·Filed 2022·Application pending·0 cites
- 1654US2025163180A1Anti-her2/anti-4-1bb bispecific antibody and use thereofABL BIO INC·Filed 2025·Application pending·0 cites
- 1750US2024383983A1Anti-B7-H4/Anti-4-1BB Bispecific Antibodies And Use ThereofABL BIO INC·Filed 2021·Application pending·0 cites
- 1848US2023212217A1Method for Purifying Biologically Active Peptide by Using Protein A Affinity ChromatographyABL BIO INC·Filed 2020·Application pending·0 cites
- 1947US12122830B1Anti-ROR1 antibody and use thereofABL BIO INC·Filed 2019·Granted Oct 22, 2024·0 cites·16 claims
- 2047US2023192861A1Anti-pd-l1/anti-b7-h3 multispecific antibodies and uses thereofABL BIO INC·Filed 2020·Application pending·0 cites
- 2146US12173070B2Anti-PD-L1/anti-LAG3 bispecific antibodies and uses thereofABL BIO INC·Filed 2019·Granted Dec 24, 2024·0 cites·9 claims
- 2246US2022125944A1Antibody-drug conjugate and use thereofABL BIO INC·Filed 2020·Application pending·0 cites
- 2343US12049493B2Anti-alpha-synuclein antibodies and uses thereofABL BIO INC·Filed 2018·Granted Jul 30, 2024·0 cites·20 claims
- 2441US12577314B2Anti-BCMA/anti-4-1BB bispecific antibodies and uses thereofABL BIO INC·Filed 2020·Granted Mar 17, 2026·0 cites·11 claims
- 2540US2023279085A1ANTIBODIES TO alpha-SYNUCLEIN AND USES THEREOFABL BIO INC·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →